Clinical characteristics and outcomes associated with BRAF and NRAS mutations in metastatic melanoma

被引：9
|
作者：
Jakob, J. A. [1 ]
Bassett, R. L. [1 ]
Ng, C. S. [1 ]
Lazar, A. J. F. [1 ]
Alvarado, G. C. [1 ]
Rohlfs, M. L. [1 ]
Richard, J. [1 ]
Gershenwald, J. E. [1 ]
Hwu, P. [1 ]
Kim, K. B. [1 ]
Davies, M. A. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.8500
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8500
引用
收藏
页数：1
相关论文
共 50 条
  • [21] BRAF and NRAS Mutations in Nodular and Superficial Spreading Melanoma
    Bossler, A. D.
    Snow, A. N.
    Knutson, T. M.
    Button, A. M.
    Milhem, M. M.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2013, 15 (06): : 908 - 908
  • [22] KRAS, NRAS and BRAF mutations in colorectal cancer and melanoma
    Jonas Cicenas
    Linas Tamosaitis
    Kotryna Kvederaviciute
    Ricardas Tarvydas
    Gintare Staniute
    Karthik Kalyan
    Edita Meskinyte-Kausiliene
    Vaidotas Stankevicius
    Mindaugas Valius
    Medical Oncology, 2017, 34
  • [23] KIT, NRAS, and BRAF mutations in nail apparatus melanoma
    Dika, E.
    Altimari, A.
    Patrizi, A.
    Gruppioni, E.
    Fiorentino, M.
    Piraccini, B. M.
    Misciali, C.
    Barisani, A.
    Fanti, P. A.
    PIGMENT CELL & MELANOMA RESEARCH, 2013, 26 (05) : 758 - 760
  • [24] KIT, NRAS and BRAF Mutations in Nail Apparatus Melanoma
    Dika, E.
    Altimari, A.
    Fiorentino, M.
    Patrizi, A.
    Piraccini, B. M.
    Gruppioni, E.
    Barisani, A.
    Fanti, P. A.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 41 - 41
  • [25] NRAS and BRAF mutations in melanoma turnours in re ation to clinical characteristics:: a study based on mutation screening by pyrosequencing
    Edlundh-Rose, Esther
    Egyhazi, Suzanne
    Omholt, Katarina
    Mansson-Brahme, Eva
    Platz, Anton
    Hansson, Johan
    Lundeberg, Joakim
    MELANOMA RESEARCH, 2006, 16 (06) : 471 - 478
  • [26] Disseminated intravascular coagulation and melanoma: a novel case occurring in metastatic melanoma with BRAF and NRAS mutations and systematic review
    Haggstrom, Lucy
    Duong, Tuan Anh
    Thomas, Benjamin
    Brungs, Daniel
    Aghmesheh, Morteza
    Parmar, Gurdeep
    MELANOMA RESEARCH, 2019, 29 (05) : 533 - 538
  • [27] Influence of BRAF and NRAS Mutations on Distant Intracranial Recurrence and Survival in Metastatic Melanoma Following Radiosurgery
    Rutter, C. E.
    Giesen, E.
    Yu, J. B.
    Bindra, R. S.
    Kluger, H. M.
    Chiang, V. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S275 - S275
  • [28] Low BRAF and NRAS expression levels are associated with clinical benefit from DTIC therapy and prognosis in metastatic melanoma
    Einar Birkeland
    Christian Busch
    Elisabet Ognedal Berge
    Jürgen Geisler
    Göran Jönsson
    Johan Richard Lillehaug
    Stian Knappskog
    Per Eystein Lønning
    Clinical & Experimental Metastasis, 2013, 30 : 867 - 876
  • [29] BRAF and NRAS Mutations are Not Mutually Exclusive in Melanoma and in Single Melanoma Cells
    Uguen, Arnaud
    Gueguen, Paul
    Talagas, Matthieu
    Costa, Sebastian
    De Braekeleer, Marc
    Marcorelles, Pascale
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2016, 24 (03) : E14 - E15
  • [30] Low BRAF and NRAS expression levels are associated with clinical benefit from DTIC therapy and prognosis in metastatic melanoma
    Birkeland, Einar
    Busch, Christian
    Berge, Elisabet Ognedal
    Geisler, Jurgen
    Jonsson, Goran
    Lillehaug, Johan Richard
    Knappskog, Stian
    Lonning, Per Eystein
    CLINICAL & EXPERIMENTAL METASTASIS, 2013, 30 (07) : 867 - 876
12345